Hospitals

atai Life Sciences and Massachusetts General Hospital Announce Initiation of Clinical Study Investigating Neuroplasticity Biomarkers in Treatment-Resistant Depression Patients Undergoing Ketamine Treatment

QHSLab, Inc. Projects a $7.5 Billion Addressable Market for its Integrated Service Program (ISP) Digital Health Solution Designed For Primary Care

This forecast is based on estimates generated through a recent pilot program and scaled through approximately 250,000 independent primary care...

Intermountain Healthcare Researchers Find Most Commonly Prescribed Class of Anti-Depressant Medications Do Not Reduce COVID Severity

Intermountain Healthcare caregiver visits with a patient Intermountain researchers examined 33,088 people who tested positive for COVID-19 between March 14,...

SeaStar Medical (Nasdaq: ICU) Announces Positive Interim Safety Findings from Ongoing Study Evaluating the Selective Cytopheretic Device (SCD) in Children

Data being presented at the American Society of Nephrology (ASN) Kidney Week 2022 Interim study data show that SCD treatment...

Accelus Announces FDA 510(k) Clearance for Remi Robotic Navigation System Software Update that Allows Image Acquisition with all Major 3D Imaging Systems

Remi Robotic Navigation System Accelus Announces FDA 510(k) Clearance for Remi Robotic Navigation System Software Update that Allows Image Acquisition...

error: Content is protected !!